TCBP - TC Biopharm GAAP EPS of $1.13 revenue of $1.2M December, 12 2022 09:19 AM TC BioPharm (Holdings) plc TC Biopharm press release ( NASDAQ: TCBP ): 1H GAAP EPS of $1.13. Revenue of $1.2M. Cash and cash equivalents were £6.0 million or $7.3 million as of June 30, 2022 compared to £1.6 million as of December 31, 2021. For further details see: TC Biopharm GAAP EPS of $1.13, revenue of $1.2M